Effects of chronic administration of codeine and promethazine on breathlessness and exercise tolerance in patients with chronic airflow obstruction.

Author: HedemarkL L, KronenbergR S, NiewoehnerD E, RiceK L

Paper Details 
Original Abstract of the Article :
It has been reported that short-term treatment with relatively high doses of opiates or promethazine causes improvements in dyspnoea and exercise tolerance in patients with chronic airflow obstruction (CAO). This study was designed to determine whether initial benefits were sustained during chronic ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/0007-0971(87)90163-x

データ提供:米国国立医学図書館(NLM)

Codeine and Promethazine: A Double-Edged Sword for Chronic Airflow Obstruction

Chronic airflow obstruction (CAO) is a serious respiratory condition that can significantly impact quality of life. This study investigates the effects of long-term codeine and promethazine treatment on breathlessness and exercise tolerance in patients with CAO. Imagine these drugs as two different paths through the desert, each offering potential benefits but also carrying risks.

Limited Benefits

The study found that chronic treatment with codeine or promethazine did not provide sustained benefits in terms of improving breathlessness or exercise tolerance. In fact, some patients experienced worsening of their CAO symptoms during treatment. It's like discovering that the desert oasis isn't as welcoming as you initially thought.

Weighing the Risks and Benefits

This research highlights the need for careful consideration when using codeine and promethazine for long-term treatment of CAO. The potential risks may outweigh the limited benefits, especially in patients with severe CAO.

Dr. Camel's Conclusion

The search for effective treatments for chronic airflow obstruction is an ongoing journey through the desert. This study reminds us that even medications that offer potential benefits can have unexpected side effects, and that careful evaluation is necessary before embarking on long-term treatment.

Date :
  1. Date Completed 1987-11-30
  2. Date Revised 2020-12-09
Further Info :

Pubmed ID

3311120

DOI: Digital Object Identifier

10.1016/0007-0971(87)90163-x

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.